Native Pharmaceuticals Private Limited
About Native Pharmaceuticals Private Limited
Data last updated:
Native Pharmaceuticals Private Limited is a private limited company based in Srinagar, Jammu And Kashmir, India. It was incorporated on 02 September 2024.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U46497JK2024PTC016450.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mymoona Akhter and Arshid Hussain Mir.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Gh Mohammad, Budoo Bagh Khanyar, Srinagar, Jammu and Kashmir, India – 190003.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.41 Lakh. For the same year it recorded a net loss of ₹10.39 Lakh (net margin -235.5%) and EBITDA of -₹10.39 Lakh (EBITDA margin -235.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Gh Mohammad, Budoo Bagh Khanyar, Srinagar, Jammu and Kashmir, India – 190003
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Native Pharmaceuticals Private Limited FY 2025 filings available
Native Pharmaceuticals Private Limited reported revenue of ₹4.41 Lakh for FY 2025.
Financial Statement Summary of Native Pharmaceuticals Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | -₹10.39 Lakh |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | -₹10.39 Lakh |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Native Pharmaceuticals Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -235.5% |
| Net Profit Margin | -235.5% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Native Pharmaceuticals are in the company report.
Financial statements from FY 2025
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Native Pharmaceuticals Private Limited
Native Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Great India Pharmaceuticals Private Limited. | ₹4.5 Lakh (FY 2025) | •••• | •••• | •••• | Ganjam, Odisha, India | |
| Padmanabha Pharmaceuticals and Cosmetics Private Limited | ₹4.49 Lakh (FY 2025) | •••• | •••• | 49744.0% | •••• | Moradabad, Uttar Pradesh, India |
| Dux Ducis Pharmaceuticals Private Limited | ₹4.46 Lakh (FY 2019) | •••• | •••• | -56.0% | •••• | Navi Mumbai, Maharashtra, India |
| Om Shrinath Pharmaceuticals Private Limited | ₹4.46 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Nagpur, Maharashtra, India |
| Rightex Pharmaceuticals Private Limited | ₹4.43 Lakh (FY 2025) | •••• | •••• | -36.0% | •••• | Jalgaon, Maharashtra, India |
| Native Pharmaceuticals Private Limited this company | ₹4.41 Lakh (FY 2025) | •••• | •••• | •••• | Srinagar, Jammu And Kashmir, India | |
| Arjita Pharmaceuticals Private Limited | ₹4.41 Lakh (FY 2024) | •••• | •••• | -45.0% | •••• | Muzaffarpur, Bihar, India |
| Sanchi Pharmaceuticals Private Limited | ₹4.4 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Fairfield Pharmaceuticals Private Limited | ₹4.39 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Gujarat, India |
| Willius Pharmaceuticals Private Limited | ₹4.37 Lakh (FY 2025) | •••• | •••• | 395.0% | •••• | Jahagirpuri, Delhi, India |
| Yeslife Pharmaceuticals Limited | ₹4.37 Lakh (FY 2022) | •••• | •••• | 119.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Native Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Native Pharmaceuticals Private Limited
Native Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mymoona Akhter | Director | 02 Sep 2024 | 2 Years 1 Months | Current |
| Arshid Hussain Mir | Director | 02 Sep 2024 | 2 Years 1 Months | Current |
Charges & Borrowings of Native Pharmaceuticals Private Limited
Native Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Native Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Native Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Native Pharmaceuticals Private Limited
Native Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Arshid Hussain Mir was appointed as Director on 02 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Native Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Native Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Native Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Native Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Native Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Native Pharmaceuticals Private Limited
Native Pharmaceuticals is an active private limited company based in Srinagar, Jammu And Kashmir, India. It was incorporated on 02 September 2024 (2+ years old) and is registered under CIN U46497JK2024PTC016450.
Native Pharmaceuticals reported revenue of ₹4.41 Lakh for FY 2025.
Native Pharmaceuticals has 2 current directors:
- Mymoona Akhter - Director
- Arshid Hussain Mir - Director
Native Pharmaceuticals reported a net loss of ₹10.39 Lakh (net margin -235.5%) and EBITDA of -₹10.39 Lakh (EBITDA margin -235.5%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Native Pharmaceuticals is U46497JK2024PTC016450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Native Pharmaceuticals was incorporated on 02 September 2024, making it 2+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Native Pharmaceuticals by revenue are Great India Pharmaceuticals Private Limited, Padmanabha Pharmaceuticals and Cosmetics Private Limited, Dux Ducis Pharmaceuticals Private Limited, Om Shrinath Pharmaceuticals Private Limited, Rightex Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Arshid Hussain Mir was appointed as Director on 02 Sep 2024. Mymoona Akhter was appointed as Director on 02 Sep 2024.
The registered office of Native Pharmaceuticals is at CO Gh Mohammad, Budoo Bagh Khanyar, Srinagar, Jammu and Kashmir, India – 190003.
Native Pharmaceuticals has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh.
No. Native Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.